James Robinson On The Drug Market, Innovation, Biosimilars, and What The French Get Right

Health Affairs Editor-in-Chief Alan Weil interviews James Robinson from the University of California, Berkeley School of Public Health on drug innovation, biosimilars, and market competition in the United States and beyond.